Assignee profile
Prospect Therapeutics Nanjing
Coverage of patents, compounds and activity records linked to this assignee.
1 patents4 compounds8 activity records
Summary
AssigneeProspect Therapeutics Nanjing
Filing years2025
Patents1
Compounds4
Activity records8
Patent families1
Targets1
Assay familiesdegradation, viability
Activity metricsDC50, Dmax, IC50
Overview
Target distribution and active-compound trend
Target distribution
8 activity records
Active compounds by publication year
Distinct compounds linked to assignee patent publications
Activity compounds and values
Activity records
| Structure | Control | Value | Concentration | Time | Record ID | Compound | Assay | Details | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | DC50 | - | <= | 10 | nM | - | — | GSPT1 | - | - | CN120865187A | PGDB_A011326 | PGDB_C003414 | PGDB_AS000817 | View |
 | DC50 | - | = | 10-50 | nM | - | — | GSPT1 | - | - | CN120865187A | PGDB_A015615 | PGDB_C003413 | PGDB_AS000881 | View |
 | IC50 | - | = | 114 | nM | - | — | GSPT1 | - | BT-474 | CN120865187A | PGDB_A024748 | PGDB_C000059 | PGDB_AS000382 | View |
| DC50 | - | = | 10-50 | nM | - | — | GSPT1 | - | - | CN120865187A | PGDB_A043986 | PGDB_C003414 | PGDB_AS000881 | View |
| Dmax | - | = | 99 | % | - | - | GSPT1 | - | - | CN120865187A | PGDB_A044587 | PGDB_C003414 | PGDB_AS002423 | View |
| Dmax | - | = | 97 | % | - | - | GSPT1 | - | - | CN120865187A | PGDB_A059191 | PGDB_C003413 | PGDB_AS002423 | View |
| IC50 | - | = | 17 | nM | - | — | GSPT1 | - | BT-474 | CN120865187A | PGDB_A060156 | PGDB_C003413 | PGDB_AS000382 | View |
 | IC50 | - | = | 17 | nM | - | — | GSPT1 | - | BT-474 | CN120865187A | PGDB_A069194 | PGDB_C003412 | PGDB_AS000382 | View |